DrugPatentWatch Database Preview
Drugs in Development Information for Batefenterol
» See Plans and Pricing
What is the development status for investigational drug Batefenterol?
Batefenterol is an investigational drug.
There have been 4 clinical trials for Batefenterol.
The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2015.
The most common disease conditions in clinical trials are Pulmonary Disease, Chronic Obstructive, Lung Diseases, and Chronic Disease. The leading clinical trial sponsors are GlaxoSmithKline, Hammersmith Medicines Research, and [disabled in preview].
There are nine US patents protecting this investigational drug and one hundred and sixty international patents.
Summary for Batefenterol
US Patents | 9 |
International Patents | 160 |
US Patent Applications | 14 |
WIPO Patent Applications | 26 |
Japanese Patent Applications | 0 |
Clinical Trial Progress | Phase 2 (2015-11-01) |
Vendors | 25 |
Recent Clinical Trials for Batefenterol
Title | Sponsor | Phase |
---|---|---|
A Phase 1 (Ph1), Single Dose (SD), GSK961081 Absorption, Distribution, Metabolism, and Excretion (ADME) Study in Healthy Subjects | Hammersmith Medicines Research | Phase 1 |
A Phase 1 (Ph1), Single Dose (SD), GSK961081 Absorption, Distribution, Metabolism, and Excretion (ADME) Study in Healthy Subjects | GlaxoSmithKline | Phase 1 |
GSK961081 Alone and With Fluticasone Furoate (FF), Phase 1 (Ph1), Single Dose Regimen (SD), Repeat Dose Regimen (RD), Pharmacokinetic (PK) Study in Healthy Volunteer (HV) | Hammersmith Medicines Research | Phase 1 |
Clinical Trial Summary for Batefenterol
Top disease conditions for Batefenterol
Top clinical trial sponsors for Batefenterol
US Patents for Batefenterol
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
Batefenterol | Start Trial | Biphenyl derivatives | Theravance, Inc. (South San Francisco, CA) | Start Trial |
Batefenterol | Start Trial | Crystalline form of a biphenyl compound | Theravance, Inc. (South San Francisco, CA) | Start Trial |
Batefenterol | Start Trial | Biphenyl derivatives | Theravance, Inc. (South San Francisco, CA) | Start Trial |
Batefenterol | Start Trial | Compound | Glaxo Group Limited (Greenford, Middlesex, GB) | Start Trial |
Batefenterol | Start Trial | Crystalline form of a biphenyl compound | Theravance, Inc. (South San Francisco, CA) | Start Trial |
Batefenterol | Start Trial | Crystalline form of a biphenyl compound | Theravance, Inc. (South San Francisco, CA) | Start Trial |
Batefenterol | Start Trial | Process for the preparation of a biphenyl-2-yl carbamic acid ester | Glaxo Group Limited (Greenford, Middlesex, GB) | Start Trial |
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Batefenterol
Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
---|---|---|---|---|
Batefenterol | Argentina | AR043176 | 2023-02-14 | Start Trial |
Batefenterol | Argentina | AR098785 | 2023-02-14 | Start Trial |
Batefenterol | Austria | AT482934 | 2023-02-14 | Start Trial |
Batefenterol | Australia | AU2004213411 | 2023-02-14 | Start Trial |
Batefenterol | Australia | AU2010219338 | 2023-02-14 | Start Trial |
Batefenterol | Brazil | BRPI0407508 | 2023-02-14 | Start Trial |
Batefenterol | Canada | CA2515777 | 2023-02-14 | Start Trial |
>Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |